Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Inclusion Criteria: Patients who meet all of the following criteria are eligible for the project: * Age ≥ 18 years * Able to understand and willing to sign written Informed Consent and to complete patient-reported-outcome assessment instruments Main project (Metatstatic NSCLC): * Confirmed non-small cell lung cancer (NSCLC) * Informed consent no later than four weeks after start of first-line systemic treatment or no later than four weeks after diagnosis for patients receiving "best supportive care only" * Stage IV, or stage IIIB/C (UICC8) if patient is ineligible for curative surgery and/or radiochemotherapy * Systemic therapy or best supportive care Satellite Stage I/II/III (NSCLC): * Confirmed non-small cell lung cancer (NSCLC) * Informed consent no later than four weeks after start of first anti-tumor treatment (including surgery and radiotherapy) or no later than four weeks after diagnosis for patients receiving "best supportive care only" (i.e. no anti-tumor treatment = no surgery, radiotherapy or systemic therapy) * Stage I, Stage II, stage IIIA, or stage IIIB/C (UICC8) * Systemic (chemo)therapy and/or radiation therapy and/or surgery or best supportive care Satellite SCLC * Confirmed Small cell lung cancer (SCLC) * Informed consent no later than four weeks after start of first anti-tumor treatment or no later than four weeks after diagnosis for patients receiving "best supportive care only" (i.e. no anti-tumor treatment = no surgery, radiotherapy or systemic therapy) * Systemic (chemo)therapy and/or radiation therapy and/or surgery or best supportive care Exclusion Criteria: none